FDA Approves World’s First Respiratory Syncytial Virus (RSV) Vaccine for Older Adults

Drug Development, Health Canada & FDA, Industry News, Study Results

The US Food and Drug Administration (FDA) has granted approval to GlaxoSmithKline (GSK) for Arexvy, the world’s first vaccine designed to protect older adults against respiratory syncytial virus (RSV). RSV is a common respiratory virus that can cause serious illness, particularly in adults over 65 years of age, and in infants and young children. It

Can Health Canada and the FDA work together to streamline the drug approval process?

Drug Development, Health Canada & FDA, Industry NewsLeave a comment

Health Canada (HC) and the Food and Drug Administration (FDA) are meeting for the first time on May 15th, 2015 to begin discussions on how the United States and Canada can make their drug approval processes more efficient. With Prime Minister Stephen Harper’s and President Barack Obama’s backing, the two agencies have formed a council